SCHEMBL6133813

SCHEMBL6133813

CC(C)NC(=O)c1nc(-c2ccccc2)c(-c2ccc(=O)n(C(C)C)n2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.40
ADORA2A P29274 3/20 0.38
ALDH1A1 P00352 3/20 0.38
ADORA1 P30542 2/20 0.38
MAPT P10636 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2B P29275 1/20 0.38
HTT P42858 1/20 0.38
XIAP P98170 1/20 0.38
POLB P06746 1/20 0.38
TACR2 P21452 1/20 0.37
P2RY6 Q15077 1/20 0.35
PHGDH O43175 1/20 0.35
PTGS2 P35354 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134642 0.90 TP53 (0.41) ALOX15TSHRCASP1KDM4ETP53
SCHEMBL6133040 0.90 GABRA5 (0.40) ALOX15TSHRCASP1KDM4EADORA2A
SCHEMBL6133470 0.88 ALDH1A1 (0.47) ALOX15TSHRCASP1KDM4EADORA2A
SCHEMBL6134087 0.88 POLB (0.40) ALOX15TSHRCASP1KDM4EALDH1A1
SCHEMBL6134138 0.88 RORC (0.40) ALOX15TSHRCASP1KDM4EALDH1A1
SCHEMBL6133811 0.88 NPC1 (0.40) KDM4ETP53ADORA2AALDH1A1ADORA1
SCHEMBL6134156 0.87 TSHR (0.42) ALOX15TSHRCASP1KDM4ETP53
SCHEMBL6133425 0.87 RET (0.41) KDM4ETP53ALDH1A1MAPTHTT
SCHEMBL6135410 0.86 RAB9A (0.44) ALOX15KDM4EALDH1A1POLBMEN1
SCHEMBL6134311 0.86 HPGD (0.41) KDM4ETP53ADORA2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR ALOX15 1491/4885TSHR 20/4885CASP1 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.